HER2 tumor marker tests are used to determine whether breast cancer is HER2 positive or negative. A person is a candidate for ...

In its fourth year, Camp Breastie offers campers a glamping experience with educational panels capped off by a party called ...

A West Lothian woman who received a breast cancer diagnosis out of the blue is taking on a marathon-length moonlit challenge.

Have you ever heard about a cancer that is "in situ"? There's a reason why it's called that -- and why it's the kind of ...

The Helsinki-based firm's test is used to automate breast cancer grading using AI-developed models, and it is integrated into the firm's breast cancer suite.

Singer Jessie J. recently shared her breast cancer journey, highlighting the importance of early detection. Breast cancer, a ...

Keri Crutchfield was no stranger to life’s challenges. As a physical therapist and a mother of three daughters, her life was ...

Aiforia releases a new CE-IVD-marked clinical AI solution for breast cancer diagnostics Aiforia Technologies Plc, Press Release, June 24, 2025 at 9:00 a.m. EEST Aiforia Technologies Plc launches a new ...

Aiforia Technologies Plc launches a new CE-IVD marked clinical AI solution for breast cancer grading. Aiforia® Breast Cancer Grading AI solution is a part of the Aiforia® Breast Cancer Suite, which ...

Researchers at the University of Turku, Finland, have created an innovative fluorescent probe that visualises the complex ...

University of Cambridge study shows how LLM GPT-4 can generate novel combinations of drugs not typically used to treat cancer to be repurposed as potential breast cancer treatment in the future.

Gabriella Patey, 31, was initially told her breast tumour was benign. Later, she was told she had terminal cancer. A third call informed her it was all a terrible mistake.